- Home
- DRIO vs GSIW Comparison
DRIO vs GSIW Comparison
Compare DRIO & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRIO
- GSIW
- Stock Information
- Founded
- DRIO 2011
- GSIW 2016
- Country
- DRIO United States
- GSIW Hong Kong
- Employees
- DRIO N/A
- GSIW N/A
- Industry
- DRIO Medical/Dental Instruments
- GSIW
- Sector
- DRIO Health Care
- GSIW
- Exchange
- DRIO Nasdaq
- GSIW Nasdaq
- Market Cap
- DRIO 30.5M
- GSIW 27.2M
- IPO Year
- DRIO N/A
- GSIW 2023
- Fundamental
- Price
- DRIO $0.72
- GSIW $1.60
- Analyst Decision
- DRIO Strong Buy
- GSIW
- Analyst Count
- DRIO 2
- GSIW 0
- Target Price
- DRIO $2.50
- GSIW N/A
- AVG Volume (30 Days)
- DRIO 129.3K
- GSIW 2.2M
- Earning Date
- DRIO 08-07-2025
- GSIW 01-01-0001
- Dividend Yield
- DRIO N/A
- GSIW N/A
- EPS Growth
- DRIO N/A
- GSIW N/A
- EPS
- DRIO N/A
- GSIW N/A
- Revenue
- DRIO $28,034,000.00
- GSIW $1,313,795.00
- Revenue This Year
- DRIO $13.66
- GSIW N/A
- Revenue Next Year
- DRIO $24.50
- GSIW N/A
- P/E Ratio
- DRIO N/A
- GSIW N/A
- Revenue Growth
- DRIO 47.20
- GSIW N/A
- 52 Week Low
- DRIO $0.50
- GSIW $0.35
- 52 Week High
- DRIO $1.55
- GSIW $12.30
- Technical
- Relative Strength Index (RSI)
- DRIO 50.61
- GSIW 74.17
- Support Level
- DRIO $0.67
- GSIW $1.48
- Resistance Level
- DRIO $0.72
- GSIW $1.64
- Average True Range (ATR)
- DRIO 0.03
- GSIW 0.13
- MACD
- DRIO 0.00
- GSIW -0.02
- Stochastic Oscillator
- DRIO 48.31
- GSIW 80.00
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.